We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
348 result(s) found, displaying 271 to 280
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA 50/1000 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride1000 mg tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/500 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride 500 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 100/1000 sitagliptin(as phosphate monohydrate) 100 mg and metformin hydrochloride 1000 mg modified release tablet bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for VELMETIA XR 50/1000 sitagliptin (as phosphate monohydrate) 50 mg and metformin hydrochloride1000 mg modified release tablet bottle.
-
Prescription medicine registrationActive ingredients: ezetimibe.
-
Prescription medicine registrationActive ingredients: pembrolizumab (rch).
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Designation or determinationOrphan drug
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PNEUMOVAX 23 pneumococcal purified capsular polysaccharides 25 microgram/0.5mL injection pre-filled syringe.